Yiling Medical Research Institute

Yiling Pharmaceutical is a leading Chinese pharmaceutical company that integrates research, production, and marketing, primarily focused on Traditional Chinese Medicine (TCM) and innovative drug development. The company is renowned for its proprietary 'Collateral Disease Theory' (Luo Bing Theory), which guides the development of treatments for cardiovascular, cerebrovascular, and respiratory diseases. Its flagship products include Lianhua Qingwen for respiratory infections and Shensong Yangxin for arrhythmias. Beyond TCM, Yiling is expanding into chemical drugs and biologics, maintaining a robust R&D infrastructure through the Yiling Medical Research Institute. The company operates a complete industrial chain from medicinal herb cultivation to high-tech manufacturing.